Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
4
×
investing
4
×
life sciences
national blog main
boston blog main
deals
boston
boston top stories
new york blog main
san francisco blog main
achaogen
adams street partners
agios pharmaceuticals
akouos
antibiotics
astellas pharmaceuticals
avapritinib
beta lactamase inhibitor
biomedical advanced research and development authority (barda)
blueprint medicines
california institute for biomedical research
cancer
cancer drugs
cstone pharmaceuticals
david e. shaw
decibel therapeutics
drug discovery
drug resistance
drugs
eli lilly
enasidenib
european medicines agency
fisogatinib
flatiron health
frequency therapeutics
genentech
harvard university
hatteras venture partners
What
medicines
4
×
drug
fda
ipo
therapeutics
affects
americans
approval
approved
bacteria
biopharma
blueprint
business
cancer
candidate
company
company’s
course
currently
date
developing
development
discover
disease
exited
experimental
fighting
frequency
growing
handiwork
hearing
helped
infections
infectious
internal
landscape
launches
loss
marketing
meds
Language
unset
Current search:
fda
×
medicines
×
investing
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections